Couldn’t post article but excerpt ... “Pfizer is charging the U.S. government $19.50 per dose—well below the $150 or $175 per dose it typically pulls in for a vaccine, [chief financial officer Frank] D’Amelio said on the company’s February earnings call. But “normal market conditions will start to kick in” as the global pandemic shifts into an endemic, D’Amelio said last week…. Those profits could get even larger once Pfizer gets out of the “pandemic-pricing environment,” D’Amelio told investors last month.”
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links